QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
NYSE:WST

West Pharmaceutical Services (WST) Stock Price, News & Analysis

$410.90
-2.10 (-0.51%)
(As of 02/8/2024 ET)
Compare
Today's Range
$407.14
▼
$413.56
50-Day Range
$338.27
▼
$413.00
52-Week Range
$264.52
▼
$415.73
Volume
352,343 shs
Average Volume
488,149 shs
Market Capitalization
$30.40 billion
P/E Ratio
55.45
Dividend Yield
0.19%
Price Target
$412.20
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

West Pharmaceutical Services MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
0.3% Upside
$412.20 Price Target
Short Interest
Healthy
1.45% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.53
Upright™ Environmental Score
News Sentiment
0.94mentions of West Pharmaceutical Services in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$353,537 Sold Last Quarter
Proj. Earnings Growth
9.35%
From $8.02 to $8.77 Per Share

Overall MarketRank™

New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.57 out of 5 stars

Medical Sector

80th out of 911 stocks

Surgical & Medical Instruments Industry

13th out of 91 stocks

See Top Rated MarketRank™ Stocks Here

WST stock logo

About West Pharmaceutical Services Stock (NYSE:WST)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

WST Stock Price History

WST Stock News Headlines

February 7, 2024 | finance.yahoo.com
West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity
February 7, 2024 | americanbankingnews.com
Jefferies Financial Group Upgrades West Pharmaceutical Services (NYSE:WST) to "Buy"
February 8, 2024 | The Oxford Club (Ad)
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets… FOR FREE!
Income Expert and Author of Get Rich With Dividends Is Giving Away His Top Income Secrets…FOR FREE!
February 6, 2024 | morningstar.com
West Pharmaceutical Services Inc
February 6, 2024 | msn.com
WST Stock: Is There More Steam Left in the Rally?
February 6, 2024 | finance.yahoo.com
At US$398, Is West Pharmaceutical Services, Inc. (NYSE:WST) Worth Looking At Closely?
February 1, 2024 | finance.yahoo.com
West to Host Fourth-Quarter and Full-Year 2023 Conference Call
January 29, 2024 | americanbankingnews.com
West Pharmaceutical Services, Inc. (NYSE:WST) Plans Quarterly Dividend of $0.20
February 8, 2024 | Behind the Markets (Ad)
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
January 29, 2024 | americanbankingnews.com
West Pharmaceutical Services, Inc. (NYSE:WST) to Issue Quarterly Dividend of $0.20
January 22, 2024 | finance.yahoo.com
Here’s Why West Pharmaceutical Services (WST) Fell in Q4
January 9, 2024 | seekingalpha.com
West Pharmaceutical Services: A Solid Buy For Long-Term Investors
January 8, 2024 | seekingalpha.com
West Pharmaceutical: Great Business, Not So Great Valuation
January 8, 2024 | benzinga.com
$1000 Invested In This Stock 15 Years Ago Would Be Worth $20,000 Today
January 4, 2024 | finance.yahoo.com
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
December 29, 2023 | theglobeandmail.com
West Pharmaceutical Services WST Bullish Daily Cycle
December 26, 2023 | fxstreet.com
West Pharmaceutical Services (WST) bullish daily cycle
December 25, 2023 | benzinga.com
Here's How Much $100 Invested In West Pharmaceutical Servs 15 Years Ago Would Be Worth Today
December 19, 2023 | markets.businessinsider.com
Hold Rating on West Pharmaceutical Services Amid Balanced Growth Prospects and Expansion Investments
December 10, 2023 | msn.com
West Pharmaceutical Services (WST) Declares $0.20 Dividend
December 6, 2023 | msn.com
West Pharmaceutical declares $0.20 dividend
December 6, 2023 | finance.yahoo.com
West Announces First-Quarter 2024 Dividend
December 5, 2023 | finance.yahoo.com
West Pharmaceutical's (WST) New Launch to Expand Portfolio
December 4, 2023 | finance.yahoo.com
West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device
November 9, 2023 | finance.yahoo.com
West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets
October 30, 2023 | finance.yahoo.com
11 Best November Dividend Stocks To Buy
October 30, 2023 | gurufocus.com
The West Pharmaceutical Services Inc (WST) Company: A Short SWOT Analysis
See More Headlines
Receive WST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for West Pharmaceutical Services and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/26/2023
Ex-Dividend for 11/15 Dividend
11/07/2023
Dividend Payable
11/15/2023
Ex-Dividend for 2/7 Dividend
1/30/2024
Dividend Payable
2/07/2024
Today
2/08/2024
Next Earnings (Confirmed)
2/15/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NYSE:WST
CUSIP
95530610
CIK
105770
Web
www.westpharma.com
Phone
(610) 594-2900
Fax
800-345-9800
Employees
13,550
Year Founded
1923

Price Target and Rating

Average Stock Price Target
$412.20
High Stock Price Target
$536.00
Low Stock Price Target
$290.00
Potential Upside/Downside
+0.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$7.41
Trailing P/E Ratio
55.45
Forward P/E Ratio
51.23
P/E Growth
3.93
Net Income
$585.90 million
Net Margins
19.11%
Pretax Margin
22.50%
Return on Equity
21.86%
Return on Assets
16.40%

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
3.70
Quick Ratio
2.89

Sales & Book Value

Annual Sales
$2.89 billion
Price / Sales
10.53
Cash Flow
$10.72 per share
Price / Cash Flow
38.32
Book Value
$36.22 per share
Price / Book
11.34

Miscellaneous

Outstanding Shares
73,990,000
Free Float
73,154,000
Market Cap
$30.40 billion
Optionable
Optionable
Beta
1.05

Social Links

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for February 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Should I Buy West Pharmaceutical Services Stock? WST Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of West Pharmaceutical Services was last updated on Sunday, February 4, 2024 at 6:59 PM.

Pros

Here are some ways that investors could benefit from investing in West Pharmaceutical Services, Inc.:

  • Strong market presence: West Pharmaceutical Services, Inc. is a well-established company in the surgical and medical instruments industry. With a history dating back to 1923, the company has built a solid reputation and has a wide customer base.
  • Diversified product portfolio: The company offers a range of containment and delivery systems for injectable drugs and healthcare products. This diversified product portfolio allows West Pharmaceutical Services to cater to the needs of various pharmaceutical and medical device companies.
  • Innovative solutions: West Pharmaceutical Services is known for its innovative solutions in drug containment and delivery. The company offers advanced reconstitution, mixing, and transfer technologies, as well as self-injection devices. These innovative solutions can enhance the safe delivery of drugs and improve patient outcomes.
  • Integrated solutions and services: In addition to its product offerings, West Pharmaceutical Services provides integrated solutions and services to its customers. These include analytical lab services, regulatory expertise, and after-sales technical support. These value-added services can strengthen customer relationships and drive long-term growth.
  • Recent financial performance: West Pharmaceutical Services has shown strong financial performance in recent periods. The company's revenue and earnings have been growing steadily, indicating a positive trend. This financial stability can be attractive to investors looking for a reliable investment option.

Cons

Investors should be bearish about investing in West Pharmaceutical Services, Inc. for these reasons:

  • Competition in the industry: The surgical and medical instruments industry is highly competitive, with many players vying for market share. West Pharmaceutical Services faces competition from both established companies and new entrants, which could impact its market position and profitability.
  • Regulatory challenges: The healthcare industry is subject to strict regulations and compliance requirements. Any changes in regulations or failure to comply with existing regulations could have a negative impact on West Pharmaceutical Services' operations and financial performance.
  • Dependency on customer demand: West Pharmaceutical Services' revenue is dependent on the demand for injectable drugs and healthcare products. Any decline in customer demand or changes in market dynamics could affect the company's sales and profitability.
  • Supply chain risks: The company relies on a complex global supply chain to source raw materials and components for its products. Disruptions in the supply chain, such as natural disasters or geopolitical events, could impact West Pharmaceutical Services' ability to deliver products to customers in a timely manner.
  • Currency exchange rate fluctuations: West Pharmaceutical Services operates in multiple regions around the world, which exposes the company to currency exchange rate fluctuations. Changes in exchange rates could affect the company's financial results, especially when it comes to international sales and expenses.














WST Stock Analysis - Frequently Asked Questions

Should I buy or sell West Pharmaceutical Services stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" WST shares.
View WST analyst ratings or view top-rated stocks.

What is West Pharmaceutical Services' stock price target for 2024?

4 equities research analysts have issued 12-month price objectives for West Pharmaceutical Services' shares. Their WST share price targets range from $290.00 to $536.00. On average, they predict the company's share price to reach $412.20 in the next year. This suggests a possible upside of 0.3% from the stock's current price.
View analysts price targets for WST or view top-rated stocks among Wall Street analysts.

How have WST shares performed in 2024?

West Pharmaceutical Services' stock was trading at $352.12 at the beginning of 2024. Since then, WST stock has increased by 16.7% and is now trading at $410.90.
View the best growth stocks for 2024 here.

When is West Pharmaceutical Services' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our WST earnings forecast.

How can I listen to West Pharmaceutical Services' earnings call?

West Pharmaceutical Services will be holding an earnings conference call on Thursday, February 15th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) released its earnings results on Thursday, October, 26th. The medical instruments supplier reported $2.16 EPS for the quarter, beating the consensus estimate of $1.86 by $0.30. The medical instruments supplier had revenue of $747.40 million for the quarter, compared to the consensus estimate of $750.31 million. West Pharmaceutical Services had a trailing twelve-month return on equity of 21.86% and a net margin of 19.11%. The company's revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned $2.03 earnings per share.
Read the conference call transcript.

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Wednesday, December 6th. Shareholders of record on Wednesday, January 31st will be paid a dividend of $0.20 per share on Wednesday, February 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date of this dividend is Tuesday, January 30th.
Read our dividend analysis for WST.

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.20%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 10.80%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 9.12% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

What ETFs hold West Pharmaceutical Services' stock?

ETFs with the largest weight of West Pharmaceutical Services (NYSE:WST) stock in their portfolio include Subversive Mental Health ETF (SANE), BTD Capital Fund (DIP), Formidable Fortress ETF (KONG), Nuveen ESG Mid-Cap Growth ETF (NUMG), Goldman Sachs Future Health Care Equity ETF (GDOC), BlackRock Future Health ETF (BMED), First Trust Indxx Medical Devices ETF (MDEV) and BlackRock Future Innovators ETF (BFTR).

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (0.90%), Riverbridge Partners LLC (0.63%), Findlay Park Partners LLP (0.62%), Charles Schwab Investment Management Inc. (0.57%), Dimensional Fund Advisors LP (0.36%) and Swiss National Bank (0.31%). Insiders that own company stock include Annette F Favorite, Bernard Birkett, Chad Winters, Charles Witherspoon, Cindy Reiss-Clark, Eric Mark Green, Quintin J Lai, Silji Abraham and Thomas W Hofmann.
View institutional ownership trends.

How do I buy shares of West Pharmaceutical Services?

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does West Pharmaceutical Services have any subsidiaries?
The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..
Read More
This page (NYSE:WST) was last updated on 2/8/2024 by MarketBeat.com Staff

My Account -